These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6547980)

  • 1. Hypolipidemic activity of 3-N-(1',8'-Naphthalimido)propionic acid in rodents.
    Hall IH; Chapman JM; Voorstad PJ; Cocolas GH
    J Pharm Sci; 1984 Jul; 73(7):956-61. PubMed ID: 6547980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.
    Hall IH; Griffin TS; Docks EL; Brotherton RJ; Futch G
    J Pharm Sci; 1986 Jul; 75(7):706-10. PubMed ID: 3761173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents.
    Hall IH; Simlot R; Day P; Wong OT; ElSourady H; Izydore RA
    Pharm Res; 1993 Aug; 10(8):1206-11. PubMed ID: 8415409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypolipidemic activity of 4-phenyl-5,5-dicarbethoxy-2-pyrrolidinone in rodents.
    Hall IH; Cocolas GH; Voorstad PJ
    J Pharm Sci; 1984 Jun; 73(6):812-5. PubMed ID: 6737268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperlipidemic activity of saccharin analogues in rodents.
    Hall IH; Voorstad PJ; Chapman JM; Cocolas GH
    J Pharm Sci; 1983 Oct; 72(10):1192-8. PubMed ID: 6644571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypolipidemic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis(trimethylamin e- carboxyborane)-dicopper(II) in rodents and its effect on lipid metabolism.
    Hall IH; Williams WL; Gilbert CJ; McPhail AT; Spielvogel BF
    J Pharm Sci; 1984 Jul; 73(7):973-7. PubMed ID: 6470964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents.
    Hall IH; Wong OT; Murthy AR; Day PA; Calvin J
    Pharmacol Res Commun; 1987 Dec; 19(12):839-58. PubMed ID: 3448609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperlipidemic activity of o-chlorobenzylsulfonamide in rodents.
    Hall IH; Wyrick SD; Voorstad PJ; Dubey A
    J Pharm Sci; 1984 Mar; 73(3):378-81. PubMed ID: 6716248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic activity of the surfactants aminimides, and their effects on lipid metabolism of rodents.
    Hall IH; Kabara JJ; Matthews TG
    Lipids; 1985 Oct; 20(10):685-92. PubMed ID: 2865666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents.
    Hall IH; Murthy AR; Wyrick SD
    J Pharm Sci; 1986 Jun; 75(6):622-6. PubMed ID: 3735111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 2-(2,4-dimethylphenyl)indan-1,3-dione on serum lipoprotein and lipid metabolism of rodents.
    Hall IH; Murthy AR; Day PA; Clavin J
    Lipids; 1988 Aug; 23(8):755-60. PubMed ID: 3185107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic activity of 6-amino-2-mercapto-5-methyl-pyrimidine-4-carboxylic acid and related derivatives in rodents.
    Hall IH; Cocolas GH; Murthy AR; Rhyne KA; Knowles M
    J Pharm Sci; 1985 Jul; 74(7):759-64. PubMed ID: 4032250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypolipidemic activity of 1-N-3-methylphthalimido-butan-3-semicarbazone in rodents.
    Wong OT; Hall IH; Chapman JM
    Pharm Res; 1989 Mar; 6(3):230-4. PubMed ID: 2726679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodents.
    Chapman JM; DeLucy P; Wong OT; Hall IH
    Lipids; 1990 Jul; 25(7):391-7. PubMed ID: 2395418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodents.
    Murthy AR; Wong OT; Reynolds DJ; Hall IH
    Pharm Res; 1987 Feb; 4(1):21-7. PubMed ID: 3508524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
    Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
    Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodents.
    Simlot R; Izydore RA; Wong OT; Hall IH
    J Pharm Sci; 1994 Mar; 83(3):367-71. PubMed ID: 8207683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity of the hypolipidemic agent, N2-n-butylindazolone.
    Hall IH; Williams WL; Wyrick SD; Voorstad PJ
    J Pharm Sci; 1984 Dec; 73(12):1788-91. PubMed ID: 6527257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents.
    Izydore RA; Wong OT; Hall IH
    Lipids; 1993 Mar; 28(3):223-9. PubMed ID: 8464353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.